Board summary
Key figures
27,163
Registered population
58.5% aged 18–64
24.1%
Aged 65+
ICB 20.0% · England 17.9%
4.8%
Ethnic minority (non-White)
2.4% Asian · England 9.6%
35.6%
In IMD quintile 1
ICB 30.6% · England 21.0%
~9,826
Core20 residents (est.)
Resident basis; registered basis ~9,566 · see page 3
5,978
Hypertension register
+5.88% in 3 yrs · England +5.60%
499
SMI register
16.3% of Blackpool (LAD)'s
1,111
COPD register
Reviews -1.62% in 3 yrs
Forecast to 2030
6,604
Hypertension patients, 2077
+626 on today
71.0%
QRISK ≥20% on statins, 2077
+3.73pp over 3 yrs
7.2%
Cancer prevalence, 2077
England 4.5%
Three things the board should see
Asthma review coverage trails England and ICB.
Annual asthma review coverage is 61.4% against 65.7% in England, leaving about 810 of 2,104 register patients without a recorded review.
Pre-school MMR2 coverage sits below 95.0% target.
Age-5 MMR2 reaches 86.0% (cohort 57), sitting 9 pp below the 95.0% target, with a 10.5 pp MMR1-to-MMR2 difference at Glenroyd Medical Centre.
Diabetes HbA1c and SMI checks rose strongly.
Three-year non-frail diabetes HbA1c control rose +15.9% (England +4.4%), while mental health register BMI recording rose +13.3 pp (England +5.1 pp).
Population, age and ethnicity
Patients aged 65+ reach 24.1%, sitting 6.2 percentage points above England
Blackpool North PCN registers 27,163 patients across North Shore Surgery (13,850) and Glenroyd Medical Centre (13,313). Both serve older populations, with 24.1% (6,538 patients) aged 65+ overall (Glenroyd Medical Centre 24.8%, North Shore Surgery 23.4%), compared with 20.4% in Blackpool (LAD), 20.0% in the ICB, and 17.9% in England. Patients aged 18-64 account for 58.5% and aged 0-17 represent 17.4%. Census resident estimates show 95.2% White ethnicity (Blackpool 94.7%, ICB 87.8%, England 81.1%), with a 4.8% ethnic minority share including 2.4% Asian or Asian British. This older demographic may heighten multi-morbidity care demand.
Age profile
65+: ICB 20.0%, England 17.9%
Ethnicity
Older people · falls rows are Blackpool (LAD) local-authority (LA) data, not PCN
| Measure | Local | North West | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Blackpool LA) | 1,647 | 2,071 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 85.1% | 82.9% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 55.8% | 56.6% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Blackpool LA) | 955 | 1,021 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Blackpool LA) | 16.9 | 18.2 | 14.8 | 2022‑24 |
Deprivation and Core20
At 35.6%, Core20 deprivation exceeds England and is balanced across both practices
Core20 patients comprise 35.6% of the registered list (weighted practice share 35.2%; England 21.0%; Blackpool LAD 55.1%), alongside about 9,800 LSOA residents. Deprivation is balanced, spanning 34.3% at Glenroyd Medical Centre (4,565 estimated patients) to 36.1% at North Shore Surgery (5,001 estimated patients), a 1.8 pp spread. On a severe mental illness register of 499 patients (1.8% vs England 1.0%), checks trail England for blood pressure (78.5% vs 83.4%) and BMI (74.7% vs 82.1%). Balanced deprivation indicates shared outreach can address physical check shortfalls across both practices.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
499
SMI register
1.79% recorded prevalence
168
Learning disability register
0.60% recorded prevalence
32
Care homes, 874 beds
In the PCN catchment
10.9%
Provide unpaid care
Blackpool (LAD), Census 2021
The PCN records 499 severe mental illness patients (1.8% prevalence; Blackpool 1.7%, ICB 1.2%, England 1.0%) and 168 learning disability patients (0.6%, matching England). Catchment capacity includes 32 care homes with 874 beds, though sites do not establish PCN registration. Higher severe mental illness prevalence than regional and national comparators indicates ongoing routine review requirements across PCN practices.
Severe mental illness: physical health checks
On a 1.8% severe mental illness register (England 1.0%), annual physical checks trail England for blood pressure (78.5% vs 83.4%) and BMI (74.7% vs 82.1%), led by lower recording at Glenroyd Medical Centre (BP 72.6%; BMI 68.2%).
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
5,978
Hypertension register
+5.88%
Register growth, 3 yrs
Blackpool (LAD) +5.85% · England +5.60%
−0.31pp
BP control, under 80
≤140/90 · +0.96pp aged 80+
+626
More patients by 2030
Forecast 6,604 (24.08%)
Hypertension case-finding and control
Recorded hypertension prevalence is 21.5% (5,978 patients), above England (15.2%), Blackpool (19.4%) and the ICB (17.2%), alongside high stroke (2.8% vs England 1.9%) and heart failure prevalence (2.4% vs England 1.1%). However, blood pressure control has slipped over three years: patients treated to target changed -0.4% (England +3.6%) and control in under-80s changed -0.5% (England +3.2%). Additionally, hypertension patients with a recent blood pressure reading reach 86.9%, below England (90.0%), with North Shore Surgery at 84.8% compared to Glenroyd Medical Centre at 89.0%. Trailing national control trends alongside high cardiovascular prevalence suggests routine recall and medication titration should be prioritised, starting at North Shore Surgery.
Lipids and statins
Statin treatment in diabetes without cardiovascular disease is 68.4%, below England (73.2%), Blackpool (71.2%) and the ICB (71.3%), with North Shore Surgery at 59.6% and Glenroyd Medical Centre at 78.1%. Lower secondary prevention coverage than England suggests an opportunity to expand proactive lipid-lowering therapy in diabetic patients, focusing first on North Shore Surgery.
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 75,943 | £1.10 | £1.64 | £1.86 | £83,537 |
| Cardiovascular (all), 2025 | 112,593 | £3.05 | £3.38 | £3.33 | £343,409 |
For lipid-regulating drugs in 2026, the PCN prescribed 75,943 items at £1.10 per item, below England (£1.86), Blackpool (£1.49) and the ICB (£1.64), spending £57,717 less than at England's unit cost. Spending less per item than England may offer flexibility when reviewing lipid prescribing volume.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
+7.32%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
+4.36%
Asthma prevalence, PCN 3-yr % change
COPD prevalence is 4.0% (1,111 patients) against 1.9% in England, yet 12-month review coverage fell 1.6% over three years (England +2.8%) to 74.2% (England 76.4%; ICB 76.9%). The asthma register covers 2,104 patients (8.0% vs England 6.6%), but annual reviews reach 61.4% (England 65.7%), leaving about 810 patients unreviewed. Furthermore, asthma prescribing for ages 5-19 is 2,555 items per 1,000 (England 1,488), while second-hand smoke recording for ages 6-19 is 67.2% (England 78.8%).
Cancer register and children's immunisation
Cancer prevalence is 5.6% (1,566 patients) against 3.8% in England. Early childhood immunisation is strong, with 24-month MMR1 at 97.7%. However, age-5 MMR2 coverage drops to 86.0%, below the 95.0% target by 9 pp, alongside an 87.7% 4-in-1 booster rate. At age 5, same-cohort MMR1 to MMR2 shows a 5.2 pp gap across the PCN, widening to a 10.5 pp difference at Glenroyd Medical Centre (94.7% vs 84.2%).
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
52.4%
Lancashire and South Cumbria ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~2,010
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Lancashire and South Cumbria ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Breast | 86.0% | 85.4% | 6% | 1,561 |
| Prostate | 42.4% | 53.2% | 11% | 1,404 |
| Lung | 31.1% | 33.8% | 15% | 1,374 |
| Bowel | 44.2% | 47.0% | 13% | 1,198 |
| Skin cancer | 86.1% | 87.8% | 21% | 519 |
In 2022, 52.4% of cancers across NHS Lancashire and South Cumbria ICB were diagnosed at stage 1 or 2 (4,642 of 8,863 known-stage cancers; 74.6% known-stage share), trailing England (55.3%) and sitting 22.6 pp below the 75.0% national ambition by 2028. Across the ICB, early-stage share fell 1.2 pp from 53.6% in 2013, requiring about 2,010 extra early-stage cases annually to achieve 75.0%. Early detection varied widely by site, including 86.0% in breast, 44.2% in bowel and 31.1% in lung cancer. These wider-system figures do not reflect PCN performance, though PCN breast screening coverage lags at 67.0% (England 69.9%).
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In Jul 2026 (provisional), Blackpool Teaching Hospitals NHS Foundation Trust achieved 67.5% on the cancer 62-day referral to treatment standard (below the 85.0% standard by 17.5 pp), behind Lancashire Teaching Hospitals NHS Foundation Trust (75.0%), University Hospitals of Morecambe Bay NHS Foundation Trust (72.4%), NHS Lancashire and South Cumbria Integrated Care Board (73.6%) and England (71.2%). On the 28-day faster diagnosis standard, Blackpool Teaching Hospitals NHS Foundation Trust reached 71.4% (standard 75.0%), trailing Lancashire Teaching Hospitals NHS Foundation Trust (82.9%), the ICB (78.4%) and England (79.3%). Diagnostic 6+ week waits stood at 26.5% (England 23.1%).
| Pathways within standard (%) | Blackpool | Lancashire | of Morecambe Bay | Lancashire and South Cumbria ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 71.38 | 82.90 | 78.39 | 78.39 | 79.32 |
| 31-day treatment (96%) | 97.96 | 89.43 | 95.22 | 93.62 | 92.50 |
| 62-day referral to treatment (85%) | 67.48 | 75.04 | 72.35 | 73.62 | 71.16 |
| Diagnostic waits over 6 weeks (%) | Blackpool | Lancashire | of Morecambe Bay | England |
|---|---|---|---|---|
| MRI | 21.80 | 2.41 | 4.04 | 21.40 |
| CT | 16.49 | 14.97 | 13.76 | 9.92 |
| Echocardiography | 7.57 | 13.85 | 10.55 | 28.48 |
| Colonoscopy | 13.08 | 0.00 | 0.60 | 30.83 |
| Gastroscopy | 12.47 | 0.00 | 1.45 | 29.02 |
| All 15 DM01 tests | 26.54 | 26.65 | 10.44 | 23.14 |
| Community services activity | Blackpool residents | Lancashire and South Cumbria ICB |
|---|---|---|
| Care contacts | 28,770 | 193,720 |
| Referrals | 4,700 | 29,855 |
| Patients with a contact | 8,925 | 65,335 |
Community services (residents of Blackpool), Jun 2026 (provisional). In Jun 2026 (provisional), community health service providers recorded 28,770 care contacts for Blackpool residents, involving 8,925 individual patients and 4,700 referrals. Across NHS Lancashire and South Cumbria Integrated Care Board, activity reached 193,720 contacts and 65,335 patients. Adults aged 65+ accounted for 58.1% of Blackpool residents' contacts. These experimental figures represent resident and system-level community activity rather than dedicated PCN delivery.
Practice variation and patient experience
Practices show a 26.4 pp immunisation spread despite a 1.8 pp deprivation difference
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| North Shore | 106 | 36.1 | 59.4% | 66.9% | 76.8% |
| Glenroyd | 123 | 34.3 | 42.0% | 68.7% | 66.5% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Three-year progress trails England across 9 of 25 measures, led by routine reviews
Three-year changes trail England across 9 of 25 compared measures, led by COPD annual reviews (-1.6% vs England +2.8%) and hypertension treatment to appropriate threshold (-0.4% vs England +3.6%). Slower relative growth also appears in dementia registers (+3.4% vs England +6.0%). Conversely, non-frail diabetes HbA1c control gained +15.9% (England +4.4%), alongside strong percentage-point rises in severe mental illness alcohol (+15.4 pp vs England +5.4 pp) and BMI (+13.3 pp vs England +5.1 pp) recording.
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
COPD reviews
Hypertension treated to target
BP control, under 80
Breast screening (53-70)
Dementia register
Diabetes HbA1c control
Alcohol record (psychosis)
BMI record (SMI)
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Blackpool (LAD) | Asset | PCN | Blackpool (LAD) |
|---|---|---|---|---|---|
| Care homes (catchment) | 32 (874 beds) | n/a | Schools (catchment) | 45 | n/a |
| Children's centres | 4 | 13 | Places of worship | 23 | 62 |
| Libraries | 1 | 8 | Food banks (VCS) | 1 | 1 |
| Children and young people (VCS) | n/a | 1 | Primary schools (LA maintained) | 3 | 5 |
| Primary academies | 10 | 26 | Special schools | n/a | 1 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Structured asthma review and prescribing recall
Asthma reviews cover 61.4% of the 2,104 register (England 65.7%; ICB 65.0%), leaving 812 (about 810) unreviewed; youth prescribing is 2,555 per 1,000 (England 1,488). For discussion: the PCN could run structured asthma recall using a single template, prioritising high-prescribing children with after-school slots. Moderate effort to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Option 2
Pre-school MMR2 and booster recall
In Q1 2025/26, age-5 MMR2 coverage is 86.0% (cohort 57), 9 pp below the 95.0% target and 5.2 pp below MMR1 (91.2%), with a 10.5 pp difference at Glenroyd Medical Centre. For discussion: practices could audit age-5 cohorts for missed second MMR doses and run flexible pre-school catch-up clinics. Low cost, quick to run.
Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.
Policy anchor: 10 Year Health Plan, shift from sickness to prevention.
Option 3
Hypertension BP and diabetes statin recall
On a 5,978 hypertension register (21.5% vs England 15.2%), recent BP readings reach 86.9% vs England 90.0% (-3.0 percentage points); statins in diabetes aged 40+ without CVD reach 68.4% vs England 73.2% (-4.7 percentage points). Moderate effort to run.
Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.
Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Joint frailty and complex care review (p2) | Aged 65+ | Neighbourhood health framework · NHS vaccination strategy | PCN |
| Joint Core20 physical health outreach (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| SMI physical health check outreach (p4) | SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Hypertension recall and titration audit (p5) | Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Pre-school booster recall audit (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Breast screening uptake initiative (p7) | Breast screening coverage: aged 53 to 70 years old | — | PCN |
| Practice access and triage review (p9) | GPPS good overall experience of the practice | 10YHP, hospital to community | Practice |
| Option 1 · Structured asthma review and prescribing recall (p12) | Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 Population | Core20PLUS5 respiratory | PCN |
| Option 2 · Pre-school MMR2 and booster recall (p12) | MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Option 3 · Hypertension BP and diabetes statin recall (p12) | Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP reading | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN & Practice |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | Local authority | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
